Carcinoembryonic antigen (CEA) and cancer antigen 125 (CA125) are important tumor markers for the diagnosis of ovarian cancer at the metastasis stage. Here, CEA and CA125 were simultaneously detected by a label-free electrochemical immunosensor. Using a stencil and carbon ink, a dual carbon electrode (DCE) was fabricated on a poly(vinyl chloride) substrate. Gold particles (AuPs) were electrodeposited on the electrode as a signal amplifier and support for immobilized antibodies. Linear sweep voltammetry was utilized to detect the tumor markers based on the specific binding of antigens to antibodies. Scanning electron microscopy and atomic force microscopy were used to characterize the fabricated DCE. The results were compared to those of a commercial DCE. Using the developed DCE immunosensor, we achieved a linear range of CEA from 0.5 to 25 ng mL−1 and a linear range of CA125 from 2 to 50 U mL−1. The limits of detection of CEA and CA125 were 0.15 ng mL−1 and 0.6 U mL−1, respectively. The reliability of the immunosensor was evaluated using human serum. The results were consistent with those obtained from the reference enzyme-linked fluorescence assay. The immunosensor was integrated with a small plasma membrane to form a fluidic cell (Flu-iDCE) based on acrylic sheet. The membrane had no effect on the detection of the tumor markers with the proposed Flu-iDCE. This first report of a fluidic device integrated with a DCE demonstrates the potential of the device for point-of-care detection of CEA and CA125.
Read full abstract